Member Info for K3VMC

Shorts position reduced by Barclays, but they still have over 2% to unwind.

Happy days!!

£42.5m buyback scheme kicked in the day after I bought.

That should deter any shorting.

Joined the party today. I nearly joined yesterday, but was dithering between QHE and Helix.

I can see greater opportunity here, with flow testing in progress.

I hadn’t looked at GAMA before the recent drop, but I liked the fundamentals straight away. There is every chance that PE will compete to buy this, but I’m happy to stay here if that doesn’t happen.

0.24p paid

£9.9m MCap

7 billion barrels

News leak?

Looks good value, except when I factor in the tangerine felon. No knowing where his dementia will point him next, after his attention span for Iran dissipates. Maybe bombing France, but his obsession with Greenland clearly continues.

I suppose it depends on how much Halliburton pays him?

TrustaTrade

I ordered £10k and got £3k, but sold other stuff to buy in the market. The institutions got 80% allocation.

Remember that the placing was seriously oversubscribed. They could have taken £25m, but restricted it to £12.5m

Clearly, they wanted a decent slug of cash to pay for their shopping list, but didn’t want excessive dilution.

I see no churn from institutions and very little from HNWs, since there were no warrants on offer. Barring any MM shenanigans, I call this the floor.

All imho

Terry_Tibbs

“ Closed in a matter of hours, oversubscribed, and people are selling? It beggars belief...”

There was a 50% scaleback, but I bought the shortfall in the market at a tiny premium.

MKA a solid buy at these levels, IMHO

Willy1946

“ I am reminded that some time ago you reported a conversation or statement made by Colin

That BZT would not benefit ordinary shareholders”.

Willy, that sounds like a load of balls. I doubt he thinks that, and even if he did, he wouldn’t say it! 🙄

“ · The Project remains on schedule for the anticipated delivery of first copper - gold - concentrates during the second half of 2026.”

I think our project funding was dependent on BZT showing it had broad support in the market, and that has been shown today.

I still hold BZT from the previous placing, but took today’s placing looks like being the last money in and because we will be moving into production in short order.

I didn’t have the funds available to catch the huge rises in many other miners, but I’m holding on to this one.

Latino

“ It appears placing was ONLY available to IIs and not retail investors..”

I took the placing. Not a stock that grabbed my attention in the past, but there is a lot of value here, at this mcap, so I jumped in. The market seems to like the discount as well. I would be buying at .26, if I hadn’t take the new stock at .225. TP. .47

The whole point of AIM is for new and developing companies to source finance. If you don’t like that, you should be investing in the main market, in already established companies.

The money raised buys more assets for BZT, to grow the business and create future benefit.

I took the placing. I’ve never met, or spoken with, Colin Bird. I’m certainly not one of his mates.

Shareguru22 thanks for those links. Permitting will definitely move up several gears, according to that interview.

I haven’t looked at 88e for many years now, because it was moving at glacier pace, but now, things will start to happen. I can’t stand the Trump regime, but if he facilitates a rerate on 88e, I’ll give him credit for that.

I’m in on this placing.

Small top up for me today.

GLA

Juxtaposition

“ Tim & co must be devastated that their latest production has failed to illicit a response from the market.”

Why would they care? They have the cash runway they need to get the job done. In this market, that is a HUGE hurdle they leapt over. Now, all they have to do is execute. They seem confident in that. But I’ve fallen for blatant lies in the past!! I think this will be a winner, imho.

Share price means nothing to the bod, of course.

Freetimetrader

“ Yes, I guess they are happy now that's done and they've bought themselves another 3 or 4 months until the next update !”

The £6m, plus the retail offer will give them the next 20 months cash runway.

Lots of time to generate news.

I’m happy with my 10% profit, but I can see this being a massive multi bagger, according to the hype from the bod.

NOLUPUS

Yes, I take your point.

“ The new patent on P140 is the result of impressive and dedicated research by ImmuPharma Biotech and is truly a game changer for ImmuPharma. The discovery of a new mechanism of action and identification of Type M, a sub-type of auto-immune disorders, greatly expands the scope ofP140 across a wide range of autoimmune diseases and the filing of a patent application directed towards this discovery significantly enhances the business case due to the potential for long-term increased revenues”.

I think Tim should have referred to “the new patent application on P140, so that’s definitely my bad! I seem to have more of those, with the passing of the years.

I will have to rely on the fact that Lupuzor was very effective for SOME Lupus patients, with zero deaths, as opposed to treatment currently available.

Back in regardless.

Good to see you are still here. 🙂

I can’t pretend to be interested in glucagon analogues. Any value in those will be way down the line.

Everyone seems to forget / ignore that Lupuzor was very effective for a genetic subset of P3 patients, although it didn’t meet the P3 end point overall. Therefore it has value as a therapy. Also, a patent has been granted for “something else”, which is also useful, or why would it be applied for, or granted.

Either there are deals in the pipeline, or not. We don’t have many months to wait, so I’m back in at this price.

All imho.